All data are based on the daily closing price as of July 22, 2024
f

Formosa Laboratories

4746.TW
3.23 USD
-0.04
-1.22%

Overview

Last close
3.23 usd
Market cap
388.09M usd
52 week high
3.74 usd
52 week low
2.20 usd
Target price
3.93 usd

Valuation

P/E
232.6087
Forward P/E
N/A
Price/Sales
3.1164
Price/Book Value
1.7949
Enterprise Value
454.86M usd
EV/Revenue
3.4728
EV/EBITDA
22.7556

Key financials

Revenue TTM
138.89M usd
Gross Profit TTM
42.32M usd
EBITDA TTM
36.18M usd
Earnings per Share
0.01 usd
Dividend
N/A usd
Total assets
419.52M usd
Net debt
75.65M usd

About

Formosa Laboratories, Inc., together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers worldwide. It offers APIs in the areas of anticancer, anti-inflammatory and analgesic agents, MRI enhancing agents, cholesterol and phosphate binders, CNS agents, immunomodulators, respiratory agents, steroids, vitamin D derivatives, antibiotics, potassium binders, and other areas. The company also provides contract development and manufacturing services; solutions for manufacturing antibody-drug conjugates; and injectable manufacturing services. In addition, it is involved in chemical trading; investment; and wholesale of chemical raw materials and products, as well as commission agency activities. Formosa Laboratories, Inc. was incorporated in 1985 and is headquartered in Taoyuan, Taiwan.
  • Symbol
    4746.TW
  • Exchange
    TW
  • Isin
    TW0004746003
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Dr. Chih-Ping Yang
  • Headquarter
    Taoyuan
  • Web site
    https://www.formosalab.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top